Видео ютуба по тегу Neoadjuvant Setting

Neoadjuvant and Adjuvant Chemotherapy | Part II: Clinical Studies, Side Effects & Future
Neoadjuvant and Adjuvant Chemotherapy | Part II: Clinical Studies, Side Effects & Future
Session 7: Extent of surgery post neoadjuvant – setting: Estimating the extent of surgery (Flori...
Session 7: Extent of surgery post neoadjuvant – setting: Estimating the extent of surgery (Flori...
Immunotherapy biomarkers in neoadjuvant breast cancer
Immunotherapy biomarkers in neoadjuvant breast cancer
Future directions for neoadjuvant immunotherapy in lung cancer
Future directions for neoadjuvant immunotherapy in lung cancer
Neoadjuvant immunotherapy strategies for challenging endometrial cancer
Neoadjuvant immunotherapy strategies for challenging endometrial cancer
Neoadjuvant Therapy Recommendations in Pancreas Cancer
Neoadjuvant Therapy Recommendations in Pancreas Cancer
EV-103 Cohort H: neoadjuvant enfortumab vedotin monotherapy in cisplatin-ineligible MIBC
EV-103 Cohort H: neoadjuvant enfortumab vedotin monotherapy in cisplatin-ineligible MIBC
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline
Dr. Ahn on Neoadjuvant Treatments for Patients With Gastric Cancer
Dr. Ahn on Neoadjuvant Treatments for Patients With Gastric Cancer
Hot topics in breast cancer in 2023 - what is coming next?
Hot topics in breast cancer in 2023 - what is coming next?
Neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccRCC
Neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccRCC
Dr Yee on Neoadjuvant Datopotamab Deruxtecan in High-Risk, Early-Stage Breast Cancer
Dr Yee on Neoadjuvant Datopotamab Deruxtecan in High-Risk, Early-Stage Breast Cancer
Neoadjuvant immunotherapy on the horizon in gastric cancers: 2022 ESMO Florida
Neoadjuvant immunotherapy on the horizon in gastric cancers: 2022 ESMO Florida
Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients
Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients
Advanced Pancreatic Cancer: Options in the Adjuvant Setting
Advanced Pancreatic Cancer: Options in the Adjuvant Setting
Neoadjuvant Therapy for HER2+ Breast Cancer
Neoadjuvant Therapy for HER2+ Breast Cancer
Neoadjuvant Therapy Versus Surgery for Ovarian Cancer
Neoadjuvant Therapy Versus Surgery for Ovarian Cancer
BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle...
BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle...
NEOAVAX Trial: Neoadjuvant Avelumab and Axitinib for Localized High-Risk RCC
NEOAVAX Trial: Neoadjuvant Avelumab and Axitinib for Localized High-Risk RCC
Will neoadjuvant targeted therapies play a role in NSCLC?
Will neoadjuvant targeted therapies play a role in NSCLC?
Live CMB: Genomic assays in the neoadjuvant setting: are we ready yet? Extended hormone therapy.
Live CMB: Genomic assays in the neoadjuvant setting: are we ready yet? Extended hormone therapy.
OncoDaily Highlights from ESMO with Karima Oualla։ Breast cancer in Neoadjuvant Setting
OncoDaily Highlights from ESMO with Karima Oualla։ Breast cancer in Neoadjuvant Setting
The case for neoadjuvant pembrolizumab in TNBC
The case for neoadjuvant pembrolizumab in TNBC
Daneng Li, MD, regarding the role of immunotherapy in the neoadjuvant and adjuvant setting for HCC
Daneng Li, MD, regarding the role of immunotherapy in the neoadjuvant and adjuvant setting for HCC
Neoadjuvant immunotherapy in MSI-high colorectal cancer
Neoadjuvant immunotherapy in MSI-high colorectal cancer